Publications: Dr Thomas Erblich

Aries JA, Davies JK, Auer RL, Hallam SL, Montoto S, Smith M, Sevillano B, Foggo V et al. ( 2020 ) . Clinical Outcome of Coronavirus Disease 2019 in Haemato-oncology Patients . British Journal of Haematology

Erblich T, Hibbs S, Araf S, Butler T, Bowles L ( 2020 ) . The feasibility and impact of teaching haematology registrars via a web-based videoconferencing system . BRITISH JOURNAL OF HAEMATOLOGY . vol. 189 , 195 - 195 .

Erblich T, Montoto S ( 2018 ) . Treating relapsed follicular lymphoma . Expert Review of Hematology vol. 11 , ( 5 ) 403 - 410 .

Atkins O, Erblich T, Howard J, Malaspina A ( 2016 ) . Paraproteinameia - a rare cause of a demyelinating neuropathy . BRITISH JOURNAL OF HAEMATOLOGY . vol. 173 , 171 - 172 .

Erblich T, Hill PD, Tomlinson J, Bain BJ ( 2015 ) . The complex morphology of acute kidney injury with microangiopathic hemolytic anemia and hyposplenism . American Journal of Hematology vol. 90 , ( 7 ) 674 - 674 .

Zemenides S, Erblich T, Luqmani A, Bain BJ ( 2014 ) . Peripheral blood features of acute myeloid leukemia with myelodysplasia-related changes developing in a patient with sickle cell anemia . American Journal of Hematology vol. 89 , ( 10 )

Erblich T, Apperley J, Todd J, Salooja N ( 2014 ) . CARDIOVASCULAR RISK FACTORS AND BODY HABITUS IN LONG TERM SURVIVORS OF STEM CELL TRANSPLANTATION . BONE MARROW TRANSPLANTATION . vol. 49 , S277 - S278 .

Palani R, Lasa M, Giles C, Erblich T, Patel A, Ghorashian S, Bray E, Loaiza S et al. ( 2014 ) . HIGH DOSE ETOPOSIDE/GCSF IS A SAFE AND EFFECTIVE MOBILIZATION REGIMEN IN MULTIPLE MYELOMA: A SINGLE-INSTITUTION EXPERIENCE . BONE MARROW TRANSPLANTATION . vol. 49 , S534 - S534 .